| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-05 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.0002 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |